Clinical trial
Development of a New Tool for the Diagnosis and Monitoring of Fibromyalgia "FIBROKIT"
NCT05921409 is registered in ClinicalTrials.gov with Pronacera Therapeutics SL as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of a New Tool for the Diagnosis and Monitoring of Fibromyalgia "FIBROKIT"
- Lead sponsor
- Pronacera Therapeutics SL
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2021
- Completion date
- December 31, 2023
- Enrollment
- 250 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.